Pharmaceutical / Drug Definition :
Thought to inhibit prostaglandin synthesis.
In the United States, Naproxen is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Naproxen.
Registrar Corp assists Naproxen companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Naproxen (Naproxen Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Naproxen (Naproxen Suppliers)
- Processors Naproxen
- Repackers Naproxen
- Relabelers Naproxen
- Exporters Naproxen
- Importers Naproxen
For more information about Naproxen, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.